Peptide Atlas · Peptide

Thymalin

Thymalin is a polypeptide complex extracted from the thymus; the dipeptides KE (Lys-Glu) and EW (Glu-Trp) are described as its active substances.

preclinical

provisional
2 citations
0 discussions
0 followers
Tималин
thymic bioregulator
thymus polypeptide fraction

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

preclinical — animal, cell or mechanistic work — not yet about people

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

Evidence, kept apart

The Atlas never mixes evidence types into one blob. Each claim below carries the tier it actually sits in; an unresolved citation is shown and does not move the page.

Evidence map for Thymalin. Tier reflects study design, not enthusiasm.
Claim	Tier	Source
Thymalin shifted human hematopoietic stem cell marker expression in vitro	preclinical	pmid 33237528
KE and EW dipeptides as active components of Thymalin; modelling of their gene effects	preclinical	pmid 37686182

Unanswered questions

Which controlled clinical trials of thymalin, including Russian-language ones, are published? open

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.